To ensure that the SFP continues to be independent and flexible, it receives income mainly from its Partners. In 2008 the SFP received direct contributions from the European Heart Network (EHN), the European Respiratory Society (ERS), Cancer Research UK (CR UK) and the Institut National du Cancer (INCa). In 2008, the SFP also received 5000 Euros from Novartis, 5000 Euros from Pfizer and 5000 Euros from GSK. These unrestricted educational grants were used to finance the Leuven Seminar and the European interactive smokefree website.

SFP operates with minimal administrative costs to ensure that its funds are effectively and efficiently used, thus allowing most of the SFP’s funds to go directly to supporting advocacy work, publications and workshops.

Please view the 2008 SFP Annual Report , for detailed information on SFP expenditures and income in 2008.